| Gene symbol | VEGFA | Synonyms | L-VEGF, MVCD1, VEGF, VPF | Type of gene | protein-coding |
| Chromosome | 6 | Map location | 6p21.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | vascular endothelial growth factor A | ||||
| GTO ID | GTC1292 |
| Trial ID | NCT00668499 |
| Disease | Mesothelioma |
| Altered gene | VEGFA |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | Veglin |
| Phase | Phase1|Phase2 |
| Recruitment status | Withdrawn |
| Title | A Phase I/II Study of VEGF-Antisense Oligonucleotide (VEGF-AS, Veglin) in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma |
| Year | 2008 |
| Country | United States |
| Company sponsor | University of Southern California |
| Other ID(s) | 18M-07-2 |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||